Scopolamine and Hallucinations - a phase IV clinical study of FDA data
Summary:
Hallucinations is reported as a side effect among people who take Scopolamine (scopolamine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ativan, and have Nausea.
The phase IV clinical study analyzes which people have Hallucinations when taking Scopolamine. It is created by eHealthMe based on reports of 4,933 people who have side effects when taking Scopolamine from the FDA, and is updated regularly.
What is Scopolamine?
Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.
What is Hallucinations?
Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,894 drugs and 2,727 conditions by eHealthMe. Check the latest studies of Hallucinations.
4,933 people reported to have side effects when taking Scopolamine.
Among them, 117 people (2.37%) have Hallucinations.
Among these 117 people:
How long have people been on Scopolamine when they have Hallucinations? *
What is the gender of people who have Hallucinations when taking Scopolamine? *
What is the age of people who have Hallucinations when taking Scopolamine? *
What are other drugs people take besides Scopolamine? *
What are other side effects people have besides Hallucinations? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Scopolamine and have Hallucinations?
- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Scopolamine:
- Scopolamine (4,945 reports)
Hallucinations treatments and more:
- Hallucinations (98,683 reports)
How severe was Hallucinations and when was it recovered:
Expand to all the drugs that have ingredients of scopolamine:
- Hallucinations and drugs with ingredients of scopolamine (210 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Scopolamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hallucinations:
- Hallucinations (1,894 drugs)
Browse all the conditions that are associated with Hallucinations:
- Hallucinations (2,727 conditions)
Related publications that referenced our studies
- Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
- Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
- Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
- Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on scopolamine (the active ingredients of Scopolamine) and Scopolamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Librium vs. Viibryd, side effect and effectiveness comparison - 3 seconds ago
- Drug interactions of Crestor and Bydureon - 9 seconds ago
- Nausea in Keppra Xr, how severe and when it was recovered? - 12 seconds ago
- Procedural Pain and drugs of ingredients of citric acid; magnesium oxide; sodium picosulfate - 21 seconds ago
- Maxzide and Skelaxin drug interactions for women aged 40-49 - 27 seconds ago
- Joint Pain and drugs of ingredients of soy - 32 seconds ago
- Could Loestrin 24 Fe cause Vaginal Bleeding Between Periods? - 39 seconds ago
- Could Alphagan cause Macular Degeneration? - 40 seconds ago
- Drug interactions of Pentasa and Pioglitazone Hydrochloride - 42 seconds ago
- Heart Rate Decreased and Dizziness - 43 seconds ago